Determination of thalidomide by high performance liquid chromatography: Methodological strategy for clinical trials
- 31 August 1995
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 28 (4) , 467-470
- https://doi.org/10.1016/0009-9120(95)00019-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradationJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Recurrent aphthous ulcer in patient infected with human immunodeficiency virus: Successful treatment with thalidomideJournal of the American Academy of Dermatology, 1990
- Thalidomide in hyperalgic pharyngeal ulceration of AIDSThe Lancet, 1990
- Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody.BMJ, 1989
- Determination of thalidomide and its major metabolites by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- The Saga of ThalidomideNew England Journal of Medicine, 1962